Pharmaceutical

Evotec partners with Crohn’s & Colitis Foundation for IBD therapies

Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.

Jan 11, 2024 - 18:00
Evotec partners with Crohn’s & Colitis Foundation for IBD therapies
Evotec has announced a collaboration with the Crohn's & Colitis Foundation to advance drug discovery and develop new therapies for IBD.
Read the original article

Tags:

Previous Article

BridgeBio gears up for FDA review of acoramidis following Phase III results

Next Article

3M Health receives grant to develop wound treatment solutions in US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

No one’s pleased with the government’s pitch for 2025 Medicare Advantage rates

No one’s pleased with the government’s pitch for 2025 M...

Feb 13, 2024

Henrietta Lacks settlement hailed by experts as step toward correcting medicine’s racist history

Henrietta Lacks settlement hailed by experts as step to...

Aug 1, 2023

STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective

STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bu...

May 17, 2023